Foamix Pharmaceuticals Ltd. Proceeds from Convertible Debt
Foamix Pharmaceuticals Ltd. reported Proceeds from Convertible Debt of $1.50 million for the 12-month period ending 2013-12-31, per its 20-F filed 2017-02-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2017-02-21
| Period end | Proceeds from Convertible Debt 12 month |
|---|---|
| 2013-12-31 | $1.50M 20-F · filed 2017-02-21 |
| 2012-12-31 | $333.00K 20-F · filed 2015-03-17 |